Health technology firm Royal Philips has partnered with artificial intelligence (AI) technology company PathAI to develop diagnostic solutions for diseases such as cancer.
The firms will work towards applying the AI to massive pathology data sets by building deep learning applications in computational pathology for better diagnostic and treatment decisions.
Initially, applications for automatic detection and quantification of cancerous lesions in breast cancer tissue will be developed.
